RESUMEN
Chondroitin synthase KfoC is a bifunctional enzyme which polymerizes the capsular chondroitin backbone of Escherichia coli K4, composed of repeated ß3N-acetylgalactosamine (GalNAc)-ß4-glucuronic acid (GlcA) units. Sugar donors UDP-GalNAc and UDP-GlcA are the natural precursors of bacterial chondroitin synthesis. We have expressed KfoC in a recombinant strain of Escherichia coli deprived of 4-epimerase activity, thus incapable of supplying UDP-GalNAc in the bacterial cytoplasm. The strain was also co-expressing mammal galactose ß-glucuronyltransferase, providing glucuronyl-lactose from exogenously added lactose, serving as a primer of polymerization. We show by the mean of NMR analyses that in those conditions, KfoC incorporates galactose, forming a chondroitin-like polymer composed of the repeated ß3-galactose (Gal)-ß4-glucuronic acid units. We also show that when UDP-GlcNAc 4-epimerase KfoA, encoded by the K4-operon, was co-expressed and produced UDP-GalNAc, a small proportion of galactose was still incorporated into the growing chain of chondroitin.
Asunto(s)
Condroitín/síntesis química , Escherichia coli/enzimología , Galactosa/metabolismo , N-Acetilgalactosaminiltransferasas/metabolismo , Acetilglucosamina/metabolismo , Reactores Biológicos , Espectroscopía de Resonancia Magnética con Carbono-13 , Condroitín/química , Lactosa/metabolismo , Ingeniería Metabólica , Espectroscopía de Protones por Resonancia MagnéticaRESUMEN
Chondroitin sulfate (CS) is a structurally complex polyanionic glycosaminoglycan that plays essential roles in physiological processes. Here we report a facile approach to a library of CS tetra- and hexasaccharides based on the enzymatic degradation of chondroitin over 10 or 11 steps, which is the shortest synthetic route toward size-defined CS oligosaccharides reported to date. Subsequent biotinylation enabled the investigation of their interactions with growth factors, filling in the gaps of the existing research, and providing probes for further exploration of the biological functions of CS.
Asunto(s)
Condroitín/síntesis química , Condroitín/metabolismo , Hialuronoglucosaminidasa/metabolismo , Oligosacáridos/síntesis química , Conformación de Carbohidratos , Condroitín/química , Hialuronoglucosaminidasa/química , Cinética , Oligosacáridos/química , Oligosacáridos/metabolismoRESUMEN
Several threonine (Thr)- and alanine (Ala)-rich antifreeze glycoproteins (AFGPs) and polysaccharides act in nature as ice recrystallization inhibitors. Among them, the Thr-decorated capsular polysaccharide (CPS) from the cold-adapted Colwellia psychrerythraea 34H bacterium was recently investigated for its cryoprotectant activity. A semisynthetic mimic thereof was here prepared from microbial sourced chondroitin through a four-step strategy, involving a partial protection of the chondroitin polysaccharide as a key step for gaining an unprecedented quantitative amidation of its glucuronic acid units. In-depth NMR and computational analysis suggested a fairly linear conformation for the semisynthetic polysaccharide, for which the antifreeze activity by a quantitative ice recrystallization inhibition assay was measured. We compared the structure-activity relationships for the Thr-derivatized chondroitin and the natural Thr-decorated CPS from C. psychrerythraea.
Asunto(s)
Alteromonadaceae/química , Condroitín , Polisacáridos Bacterianos , Treonina/química , Condroitín/síntesis química , Condroitín/química , Polisacáridos Bacterianos/síntesis química , Polisacáridos Bacterianos/químicaRESUMEN
Carbohydrates present on cell surfaces participate in numerous biological recognition phenomena including cell-cell interactions, cancer metastasis and pathogen invasion. Therefore, synthetic carbohydrates have a potential to act as pharmaceutical substances for treatment of various pathological phenomena by inhibiting specifically the interaction between cell surface carbohydrates and their protein receptors (lectins). However, the inherently low affinity of carbohydrate-protein interactions has often been an obstacle for successful generation of carbohydrate based pharmaceuticals. Multivalent glycoconjugates, i.e. structures carrying several copies of the active carbohydrate sequence in a carrier molecule, have been constructed to overcome this problem. Here we present two novel types of multivalent carbohydrate conjugates based on chondroitin oligomer and cyclodextrin carriers. These carriers were modified to express primary amino groups, and oligosaccharides were then bound to carrier molecules by reductive amination. Multivalent conjugates were produced using the human milk type oligosaccharides LNDFH I (Lewis-b hexasaccharide), LNnT, and GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc.
Asunto(s)
Condroitín/análogos & derivados , Glicoconjugados/química , Glicoconjugados/síntesis química , Oligosacáridos/química , Oligosacáridos/síntesis química , gamma-Ciclodextrinas/química , Aminas/síntesis química , Aminas/química , Secuencia de Carbohidratos , Condroitín/síntesis química , Condroitín/química , Diaminas/química , Portadores de Fármacos/síntesis química , Portadores de Fármacos/química , Glicoconjugados/biosíntesis , Datos de Secuencia Molecular , Resonancia Magnética Nuclear Biomolecular , Oligosacáridos/biosíntesis , Oxidación-Reducción , Sialiltransferasas/metabolismo , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , gamma-Ciclodextrinas/síntesis química , beta-D-Galactósido alfa 2-6-SialiltransferasaRESUMEN
A thio-linked disaccharide based on the structure of the glycosaminoglycan chondroitin was synthesized as a potential inhibitor of chondroitin AC lyase from Flavobacterium heparinum for structural analysis of the active site. Instead it was found to be a slow substrate, thereby demonstrating that lyases, in contrast to glycosidases, can cleave thioglycoside links between sugars.
Asunto(s)
Condroitín/síntesis química , Condroitín/farmacología , Disacáridos/química , Polisacárido Liasas/antagonistas & inhibidores , Compuestos de Sulfhidrilo/química , Secuencia de Carbohidratos , Condroitín/química , Disacáridos/síntesis química , Disacáridos/farmacología , Flavobacterium/enzimología , Cinética , Estructura Molecular , Polisacárido Liasas/metabolismoRESUMEN
The enzymatic polymerization to provide synthetic chondroitin and its derivatives is reported here, the first example of such in vitro synthesis to date. N-Acetylchondrosine (GlcAbeta(1-->3)GalNAc) oxazoline (1a) and its derivatives (1b-1f) were designed and synthesized as novel transition state analogue substrate monomers for catalysis by hyaluronidase. Hyaluronidase is a hydrolysis enzyme of chondroitin that also catalyzes the formation of repeated glycosidic bonds in in vitro synthesis, rather than in the catabolic direction. Monomers of 2-methyl (1a), 2-ethyl (1b), and 2-vinyl (1f) oxazoline derivatives were polymerized using this enzyme, via ring-opening polyaddition with total control of regioselectivity and stereochemistry. These reactions provided the corresponding synthetic chondroitin (natural type; N-acetyl, 2a) and the derivatives (unnatural type) with N-propionyl (2b) and N-acryloyl (2f) functional groups at the C2 position of all the galactosamine units, in good yields. Monomers of 2-n-propyl (1c) and 2-isopropyl (1d) oxazoline derivatives were polymerized to produce 2c and 2d in low yield. The 2-phenyl oxazoline derivative (1e) did not afford any enzyme-catalyzed products. M(n) values of 2a and 2b reached 4800 and 4000, respectively. The M(n) value of 2a corresponds to that of the naturally occurring chondroitin. Thus, hyaluronidase catalysis allows the in vitro production of not only natural type but also the formation of unnatural type chondroitins.